Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31037426.
- Also identified by DOI 10.1007/s00223-019-00550-z and PMC identifier 6541017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fibrous dysplasia is an uncommon mosaic disorder in which bone is replaced by structurally unsound fibro-osseous tissue. It is caused by the sporadic post-zygotic activating mutations in GNAS, resulting in dysregulated Gα<sub>S</sub>-protein signaling in affected tissues. This manifests on a broad clinical spectrum ranging from insignificant solitary lesions to severe disease with deformities, fractures, functional impairment, and pain. Fibrous dysplasia may present in isolation or in association with hyperfunctioning endocrinopathies and café-au-lait macules, known as McCune-Albright Syndrome. This review summarizes the current understanding of pathophysiology in fibrous dysplasia, describes key pre-clinical and clinical investigations, and details the current approach to diagnosis and management.
Medical subject headings
- Fibrous Dysplasia, Polyostotic
- Mutation